These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 22101077)
41. Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460. Liu ZH; Shen TY; Zhang P; Ma YL; Moyer MP; Qin HL World J Gastroenterol; 2010 Dec; 16(45):5759-65. PubMed ID: 21128328 [TBL] [Abstract][Full Text] [Related]
42. MicroRNAs as regulators of drug transporters, drug-metabolizing enzymes, and tight junctions: implication for intestinal barrier function. Ikemura K; Iwamoto T; Okuda M Pharmacol Ther; 2014 Aug; 143(2):217-24. PubMed ID: 24631272 [TBL] [Abstract][Full Text] [Related]
43. TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCζ and ERK1/2 signaling in HT-29/B6 cells. Hering NA; Richter JF; Fromm A; Wieser A; Hartmann S; Günzel D; Bücker R; Fromm M; Schulzke JD; Troeger H Mucosal Immunol; 2014 Mar; 7(2):369-78. PubMed ID: 23900194 [TBL] [Abstract][Full Text] [Related]
46. The bicistronic gene würmchen encodes two essential components for epithelial development in Drosophila. Königsmann T; Parfentev I; Urlaub H; Riedel D; Schuh R Dev Biol; 2020 Jul; 463(1):53-62. PubMed ID: 32361005 [TBL] [Abstract][Full Text] [Related]
47. Influences of nanomaterials on the barrier function of epithelial cells. Ali S; Rytting E Adv Exp Med Biol; 2014; 811():45-54. PubMed ID: 24683026 [TBL] [Abstract][Full Text] [Related]
49. New aspects of the molecular constituents of tissue barriers. Bauer HC; Traweger A; Zweimueller-Mayer J; Lehner C; Tempfer H; Krizbai I; Wilhelm I; Bauer H J Neural Transm (Vienna); 2011 Jan; 118(1):7-21. PubMed ID: 20865434 [TBL] [Abstract][Full Text] [Related]
50. Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium. Jacobi CA; Malfertheiner P Dig Dis; 2011; 29(6):600-7. PubMed ID: 22179217 [TBL] [Abstract][Full Text] [Related]
51. Secretion of Alpha-Hemolysin by Escherichia coli Disrupts Tight Junctions in Ulcerative Colitis Patients. Mirsepasi-Lauridsen HC; Du Z; Struve C; Charbon G; Karczewski J; Krogfelt KA; Petersen AM; Wells JM Clin Transl Gastroenterol; 2016 Mar; 7(3):e149. PubMed ID: 26938480 [TBL] [Abstract][Full Text] [Related]
52. The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability. Stiegeler S; Mercurio K; Iancu MA; Corr SC Cells; 2021 Nov; 10(12):. PubMed ID: 34943865 [TBL] [Abstract][Full Text] [Related]
53. Dynamic regulation of epithelial cell fate and barrier function by intercellular junctions. Koch S; Nusrat A Ann N Y Acad Sci; 2009 May; 1165():220-7. PubMed ID: 19538310 [TBL] [Abstract][Full Text] [Related]
54. Transcriptomic microRNA Profiling of Dendritic Cells in Response to Gut Microbiota-Secreted Vesicles. Díaz-Garrido N; Bonnin S; Riera M; Gíménez R; Badia J; Baldomà L Cells; 2020 Jun; 9(6):. PubMed ID: 32585977 [TBL] [Abstract][Full Text] [Related]
55. Molecular physiology and pathophysiology of tight junctions V. assault of the tight junction by enteric pathogens. Sears CL Am J Physiol Gastrointest Liver Physiol; 2000 Dec; 279(6):G1129-34. PubMed ID: 11093933 [TBL] [Abstract][Full Text] [Related]
56. Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface. Montanaro J; Inic-Kanada A; Ladurner A; Stein E; Belij S; Bintner N; Schlacher S; Schuerer N; Mayr UB; Lubitz W; Leisch N; Barisani-Asenbauer T Drug Des Devel Ther; 2015; 9():3741-54. PubMed ID: 26229437 [TBL] [Abstract][Full Text] [Related]
58. Regulation of TLR4, p38 MAPkinase, IκB and miRNAs by inactivated strains of lactobacilli in human dendritic cells. Giahi L; Aumueller E; Elmadfa I; Haslberger AG Benef Microbes; 2012 Jun; 3(2):91-8. PubMed ID: 22476320 [TBL] [Abstract][Full Text] [Related]
59. Administration of A. muciniphila ameliorates pulmonary arterial hypertension by targeting miR-208a-3p/NOVA1 axis. Bao ZY; Li HM; Zhang SB; Fei YQ; Yao MF; Li LJ Acta Pharmacol Sin; 2023 Nov; 44(11):2201-2215. PubMed ID: 37433872 [TBL] [Abstract][Full Text] [Related]
60. Global trends in research on miRNA-microbiome interaction from 2011 to 2021: A bibliometric analysis. Yan XY; Yao JP; Li YQ; Zhang W; Xi MH; Chen M; Li Y Front Pharmacol; 2022; 13():974741. PubMed ID: 36110534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]